Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Sullivan

Showing results (121-130 of 201) with videos related to

Pageof 21
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonistN H Lin, D E Gunn, Y Li, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 10, 2018
Tropical land carbon cycle responses to 2015/16 El Niño as recorded by atmospheric greenhouse gas and remote sensing dataEmanuel Gloor, Chris Wilson, Martyn P Chipperfield, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether frameworkN H Lin, M A Abreo, D E Gunn, et al.
Journal of Medicinal Chemistry|February 16, 1996
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptorsM A Abreo, N H Lin, D S Garvey, et al.
Neuropharmacology|June 1, 1996
A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligandJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.
Nature Communications|July 10, 2024
Evidence of thermophilization in Afromontane forestsAida Cuni-Sanchez, Emanuel H Martin, Eustrate Uzabaho, et al.
British Journal of Pharmacology|November 13, 2007
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain modelsB B Yao, G C Hsieh, J M Frost, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 15, 2006
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonistsM Cui, P Honore, C Zhong, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective propertiesJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.
Journal of Medicinal Chemistry|January 31, 1997
Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing propertiesN H Lin, D E Gunn, K B Ryther, et al.
Pageof 21

Showing results (121-130 of 201) with videos related to

Sort By:
Pageof 21
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonistN H Lin, D E Gunn, Y Li, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 10, 2018
Tropical land carbon cycle responses to 2015/16 El Niño as recorded by atmospheric greenhouse gas and remote sensing dataEmanuel Gloor, Chris Wilson, Martyn P Chipperfield, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether frameworkN H Lin, M A Abreo, D E Gunn, et al.
Journal of Medicinal Chemistry|February 16, 1996
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptorsM A Abreo, N H Lin, D S Garvey, et al.
Neuropharmacology|June 1, 1996
A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligandJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.
Nature Communications|July 10, 2024
Evidence of thermophilization in Afromontane forestsAida Cuni-Sanchez, Emanuel H Martin, Eustrate Uzabaho, et al.
British Journal of Pharmacology|November 13, 2007
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain modelsB B Yao, G C Hsieh, J M Frost, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 15, 2006
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonistsM Cui, P Honore, C Zhong, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective propertiesJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.
Journal of Medicinal Chemistry|January 31, 1997
Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing propertiesN H Lin, D E Gunn, K B Ryther, et al.
Pageof 21